Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Kivu Bioscience Inc.
Hoffmann-La Roche
Bayer
University of California, Irvine
ViroMissile, Inc.
Dana-Farber Cancer Institute
Kaiser Permanente
Children's Oncology Group
University of Florida
Essen Biotech
MacroGenics
Avacta Life Sciences Ltd
Institut Curie
Solve Therapeutics
Perspective Therapeutics
Ocellaris Pharma, Inc.
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Tanabe Pharma America, Inc.
University Health Network, Toronto
Blueprint Medicines Corporation
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Actym Therapeutics, Inc.
M.D. Anderson Cancer Center
Hadassah Medical Organization
Institut Bergonié
Washington University School of Medicine
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
Incyte Corporation
Leap Therapeutics, Inc.
University of California, Irvine
Baxter Healthcare Corporation
Elevation Oncology
University of South Florida
Stanford University
Mayo Clinic
Agenus Inc.
Stanford University
Cyteir Therapeutics, Inc.
Shanghai PerHum Therapeutics Co., Ltd.
NantCell, Inc.
Second Affiliated Hospital of Guangzhou Medical University
Innolake Biopharm
Pfizer
Memorial Sloan Kettering Cancer Center
UNICANCER